Crystal structure of Fab fragment of bevacizumab bound to DNA aptamer


Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
Be7v5nB1 A: beta barrelsX: Nuclear receptor ligand-binding domainH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF:ECOD (v294.2)
E [auth F]Ribosomal_L19e7v5nF1 A: beta barrelsX: Nuclear receptor ligand-binding domainH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: Ribosomal_L19ECOD (v294.2)
D [auth E]Ribosomal_L19e7v5nE1 A: beta barrelsX: Nuclear receptor ligand-binding domainH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: Ribosomal_L19ECOD (v294.2)
Ae7v5nA1 A: beta barrelsX: Nuclear receptor ligand-binding domainH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF:ECOD (v294.2)

Domain Annotation: CATH CATH Database Homepage

ChainDomainClassArchitectureTopologyHomologyProvenance Source (Version)
B2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)
E [auth F]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)
D [auth E]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)
A2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)

SAbDab Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
B,
E [auth F]
Heavy ChainIGHV3 -dna (5'-d(*gp*cp*gp*gp*tp*tp*gp*gp*tp*gp*gp*tp*ap*gp*tp*tp*ap*cp*gp*tp*tp*cp* gp*c)-3') SAbDab (2026-05-08)
A,
D [auth E]
Light ChainIGKV1 Kappadna (5'-d(*gp*cp*gp*gp*tp*tp*gp*gp*tp*gp*gp*tp*ap*gp*tp*tp*ap*cp*gp*tp*tp*cp* gp*c)-3') SAbDab (2026-05-08)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
B,
E [auth F]
Faricimab VEGFA, ANGPT2, PDCD1/CD279/PD1Therapeutic SAbDab (2026-05-08)
A,
D [auth E]
Ranibizumab VEGFA, ANGPT2, PDCD1/CD279/PD1Therapeutic SAbDab (2026-05-08)